Mark N Pellegrino - Net Worth and Insider Trading

Mark N Pellegrino Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark N Pellegrino owns 1 companies in total, including Elite Pharmaceuticals Inc (ELTP) .

Click here to see the complete history of Mark N Pellegrino’s form 4 insider trades.

Insider Ownership Summary of Mark N Pellegrino

Ticker Comapny Transaction Date Type of Owner
ELTP Elite Pharmaceuticals Inc 2023-05-01 CFO & Secretary & Treasurer

Mark N Pellegrino Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark N Pellegrino Ownership Network

Ownership Network List of Mark N Pellegrino

No Data

Ownership Network Relation of Mark N Pellegrino


Mark N Pellegrino Owned Company Details

What does Elite Pharmaceuticals Inc do?

Who are the key executives at Elite Pharmaceuticals Inc?

Mark N Pellegrino is the CFO & Secretary & Treasurer of Elite Pharmaceuticals Inc. Other key executives at Elite Pharmaceuticals Inc include Chief Commercial Officer Kirko Kirkov , CFO & Secretary & Treasurer Chen Robert C J , and CFO & Secretary & Treasurer Marc Bregman .

Elite Pharmaceuticals Inc (ELTP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Elite Pharmaceuticals Inc (ELTP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elite Pharmaceuticals Inc (ELTP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Elite Pharmaceuticals Inc (ELTP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Elite Pharmaceuticals Inc Insider Transactions

No Available Data

Mark N Pellegrino Mailing Address

Above is the net worth, insider trading, and ownership report for Mark N Pellegrino. You might contact Mark N Pellegrino via mailing address: 165 Ludlow Ave, Northvale Nj 07647.

Discussions on Mark N Pellegrino

No discussions yet.